Abstract Since mild traumatic brain injury (mTBI) often leads to neurological symptoms even without clinical MRI findings, our goal was to test whether diffuse axonal injury is quantifiable with multivoxel proton MR spectroscopic imaging ( 1 H-MRSI). T1-and T2-weighted MRI images and three-dimensional 1 H-MRSI (480 voxels over 360 cm 3 , about 30 % of the brain) were acquired at 3 T from 26 mTBI patients (mean Glasgow Coma Scale score 14.7, 18-56 years old, 3-55 days after injury) and 13 healthy matched contemporaries as controls. The N-acetylaspartate (NAA), choline (Cho), creatine (Cr) and myo-inositol (mI) concentrations and gray-matter/white-matter (GM/WM) and cerebrospinal fluid fractions were obtained in each voxel. Global GM and WM absolute metabolic concentrations were estimated using linear regression, and patients were compared with controls using two-way analysis of variance. In patients, mean NAA, Cr, Cho and mI concentrations in GM (8.4 ± 0.7, 6.9 ± 0.6, 1.3 ± 0.2, 5.5 ± 0.6 mM) and Cr, Cho and mI in WM (4.8 ± 0.5, 1.4 ± 0.2, 4.6 ± 0.7 mM) were not different from the values in controls. The NAA concentrations in WM, however, were significantly lower in patients than in controls (7.2 ± 0.8 vs. 7.7 ± 0.6 mM, p = 0.0125). The Cho and Cr levels in WM of patients were positively correlated with time since mTBI. This 1 H-MRSI approach allowed us to ascertain that early mTBI sequelae are (1) diffuse (not merely local), (2) neuronal (not glial), and (3) in the global WM (not GM). These findings support the hypothesis that, similar to more severe head trauma, mTBI also results in diffuse axonal injury, but that dysfunction rather than cell death dominates shortly after injury.
Introduction
Traumatic brain injury (TBI) annually accounts for 1.6 million emergency room visits and hospitalizations in the US [1] . It is suspected that many more victims do not seek medical attention or are seen at their doctor's office. Patients who do not recover add to the 1 % of the US population living with TBI-related, long-term disability [2] . Moreover, TBI from blast exposure has been described as the ''signature injury'' of the recent wars in Iraq and Afghanistan [3] with about 20 % of veterans reporting probable mild TBI (mTBI) [4] .
Characterized by less than a 30 min loss of consciousness (LOC), posttraumatic amnesia under 24 h and a Glasgow Coma Scale (GCS) score of 15-13 [5] , mTBI is the most common (about 85 %) head trauma in both the military and civilian setting [6] . While most patients experience full symptom resolution within months, from 5 % to 15 % are diagnosed with persistent postconcussive syndrome to become what has been labeled the ''miserable minority'' [7] .
TBI damage is assumed to result from the mechanical strain of sudden acceleration and deceleration that damages the axonal cytoskeleton and disrupts ionic balances. Abnormally high calcium influx impairs transport along the axon and can lead to dysfunction or axotomy followed by cell death [8, 9] . This strain can also cause vascular damage, seen by clinical MRI and CT and crucial for the acute assessment of mTBI: hemorrhages, hemosiderin and enlarged Virchow-Robin spaces [10] . All of these are presumed to be associated with underlying diffuse axonal injury (DAI) [11] which, however, is usually MRI and CT occult. This inability to assess the total disease load leads to weak correlation of imaging with clinical metrics [12] , and motivates the search for other mTBI biomarkers to direct pharmacological regimens and predict outcome.
MRI-occult mTBI damage can be studied with quantitative MR methods, e.g., diffusion tensor [13] , functional MRI [14] , and proton MR spectroscopy ( 1 H-MRS) [15] . 1 H-MRS adds unique specificity to pathological processes by quantifying surrogates: N-acetylaspartate (NAA) for neuronal integrity, creatine (Cr) for cellular energy/density, choline (Cho) for membrane turnover and myo-inositol (mI) for astroglial proliferation [15] . Most studies, however, have used single-voxel or 2D 1 H-MRS covering under 10 % of the brain, regions-of-interest (ROIs) that may not be globally representative and that also make it impossible to distinguish focal from diffuse injury. In addition, quantification with metabolite ratios may confound interpretation since Cr (a frequent denominator) levels can also be abnormal [16, 17] .
These shortcomings can be reduced with absolute metabolic quantification in multivoxel 1 H-MRS imaging ( 1 H-MRSI) over a much larger brain volume [18, 19] . Analyzing all voxels together improves the signal-to-noise ratio (SNR) for better precision, i.e., sensitivity to smaller global changes [20] , at the cost of averaging out regional metabolic variations, a reasonable trade-off for diffuse disorders. Since mTBI often leads to neurological symptoms even without clinical MRI findings, our goal was to test if DAI is quantifiable by 1 H-MRSI.
Materials and methods

Subjects
Twenty-six patients with closed-head mTBI (5 women, 21 men), aged 33 ± 11 years (mean ± standard deviation; range 18-56 years), were recruited serially. Twenty-five were enrolled following emergency room visits with GCS score of 15-13 and confirmed LOC of 30 min or less. Patient 13 was referred from a physician's office, where mTBI diagnosis was based on clinical evaluation and 30 min LOC. Exclusion criteria were any MRI contraindications, substance dependencies, inability to give informed consent, HIV infection, prior TBI and history of any neurological disease. Patient demographics are presented in Table 1 . Thirteen age-and gender-matched healthy controls (5 women, 8 men), aged 33 ± 12 years (range 19-57 years) were enrolled. Their exclusion criteria were the same as for the patients, plus any findings on their T1-and T2-weighted MRI. The study was approved by the institutional ethics committee and was in accordance with the ethical standards of the 1964 Declaration of Helsinki and all participants gave written informed consent.
MR data acquisition
All experiments were done in a 3-T MRI scanner (Trio; Siemens AG, Erlangen, Germany) with a TEM3000 (MR Instruments, Minneapolis, MN) circularly polarized transmit-receive head coil. For image guidance of the 1 H-MRSI volume-of-interest (VOI), we acquired 30 3.7-mm thick axial T2-weighted fluid-attenuated inversion recovery (FLAIR) images: TE/TI/TR 88/2,500/9,000 ms, 256 9 256 mm field-of-view (FOV) and 512 9 512 matrix. For tissue segmentation, we acquired sagittal magnetization prepared rapid gradient echo (MP-RAGE): TE/TI/TR 2.6/ 800/1,360 ms, 256 9 256 9 160 mm FOV and 256 9 256 9 160 matrix. The MP-RAGE was reconstructed in axial, sagittal and coronal slices (1 mm 3 isotropic pixels) at an angle rendering the genu and splenium of the corpus callosum in the same horizontal plane at the level of the longitudinal fissure, as shown in Fig. 1a .
Our auto-shim procedure based on chemical shift imaging (CSI) then adjusted the scanner's first-and second-order currents in 3-5 min [21] . Next, a 360-cm 3 1 H-MRSI VOI (10 9 8 9 4.5 cm, anterior-posterior 9 left-right 9 inferior-superior, AP 9 LR 9 IS) was image-guided over the corpus callosum, as shown in Fig. 1 . The VOI was excited with TE/TR 35/1,800 ms PRESS in three 1.5-cm thick, second-order Hadamard encoded slabs (six slices) interleaved every TR in the IS direction (Fig. 1c) for optimal SNR and spatial coverage [22] . These slices were partitioned with 2D 16 9 16 CSI over a 16 9 16-cm FOV to yield 1.0 9 1.0 9 0.75-cm nominal voxels as shown in Fig. 1 . The 8 9 10-cm (LR 9 AP) VOI was defined in their planes with two 11.2-ms long numerically optimized 180°RF pulses (4.5 kHz bandwidth) under 1.34 and 1.1 mT/m gradients to yield 8 9 10 9 6 = 480 voxels. The MR signal was acquired for 256 ms at ±1 kHz bandwidth. At two averages, the 1 H-MRSI took 34 min and the entire protocol less than an hour.
Voxel tissue segmentation
The MP-RAGE images were segmented using SPM2 (Wellcome Department of Cognitive Neurology, Institute of Neurology, London, UK [23] ) to obtain CSF, WM and GM masks. These were coregistered with the 1 H-MRSI grid using in-house software (MATLAB 2009b; The MathWorks Inc., Natick, MA), as shown in Fig. 2 , yielding their volume contribution to every jth voxel in the kth subject: a Most to least common: H headache, NS neck stiffness, D dizziness, M memory deficits, N nausea, P photophobia, S sleep disturbance, PH paresthesia (hand), V blurred vision.
Metabolic quantification
The 1 H-MRSI data were processed offline using in-house software written in IDL (Research Systems Inc., Boulder, CO). The data were voxel-shifted to align the NAA grid with the VOI. The data were then Fourier-transformed in the time, AP and LR dimensions and Hadamard-reconstructed along the IS direction. The 480 spectra were each frequency-aligned and zero-order phase-corrected in reference to the NAA peak. Voxels which demonstrated lipid contamination were excluded from the analysis.
Relative levels of the ith (i = NAA, Cr, Cho, mI) metabolite in the jth (j = 1, …, 480) voxel in the kth (k = 1, …, 39) subject were obtained from their peak area, S ijk , using SITools-FITT parametric spectral modeling software package [24] . The S ijk -s were scaled into absolute millimole amounts, Q ijk , relative to a 2-L sphere of C vitro i = 12.5, 10.0, 3.0 and 7.5 mM NAA, Cr, Cho and mI in water:
where V is the voxel volume, S ijR is the metabolite signal from the voxels of the sphere, P 180 j and P 180 R the RF power for a nonselective 1 ms 180°inversion pulse on the kth subject and reference.
Average VOI tissue concentrations, Q ik , were corrected for the relaxation time differences between each metabolite, i, in vivo (T 
Literature 3-T T vivo 1 [25] and T The average tissue concentration in the VOI for each metabolite, C ik was obtained as:
The sum of all voxels, C ik , has the advantage of about a 22-fold lower variance [(number of voxels) ] than individual voxels, and consequently is expected to yield better precision [20] .
Global WM and GM concentrations
Since the CSF does not contribute to the 1 H-MRSI signals, the ith metabolite amount in the jth voxel in the kth subject can be modeled as a sum of two compartments (GM, WM): and V GM jk independent coefficients. The resulting over-determined 480 equation system was therefore solved for the optimal C WM ik and C GM ik using linear regression [19] .
Statistical analyses
Two-way analysis of variance was used to compare the means of each metabolite between patients and controls. A separate analysis was conducted for each metabolite globally, and in WM and GM. In each case, the observed metabolite values constituted the dependent variable, while the model included subject group as a classification factor and the error variance was allowed to differ across subject groups to remove the unnecessary assumption of variance homogeneity. Since controls were matched to patients in age and gender, the indicator variable identifying subjects that were matched was included in the model as a blocking factor. As a result, the comparisons of global and tissuespecific concentrations were adjusted for age and gender.
Reported p values are two-sided, defined as significant for p \ 0.05, except for NAA. Since it is known to always be lower in all adult neuropathologies we looked for single- H-MRS MRI coregistration. 3D renderings of one of the six 7.5-mm thick spectroscopic slices in patient 12 in Table 1 , coregistered with its 7.5 corresponding CSF, WM and GM masks (1 mm thick each) segmented from the T1-weighted MR images using SPM. Our in-house software counted how many pixels of each mask fell into every spectroscopic voxel in the VOI to estimate its volume for the analysis of Eqs. 3 and 4 time since injury. SAS 9.0 (SAS Institute, Cary, NC) was used for all computations.
Results
In the patients the GCS score was 14.7 ± 0.5 (mean ± standard deviation) and the mean time since injury was 21 days (range 3-55 days), as shown in Table 1 . Of the four mTBI patients who had positive MRI findings, in only two (patients 11 and 16) were the findings possibly directly related to their head trauma. Five patients were on medication for a trauma-induced symptom.
Our automatic shim yielded a consistent 26 ± 3 Hz whole-head FWHM water line that decreased to 21 ± 3 Hz in the VOI without additional adjustments. An example of a VOI (size, position and spectra) is shown in Fig. 1 . Occasional lipid contamination caused up to at most ten voxels per dataset to be excluded from the analysis. The SNRs of the metabolites in the remaining approximately 18,720 voxels (39 subjects 9 480 voxels each) were NAA 30 ± 7, Cr 15 ± 3, Cho 13 ± 3 and mI 8 ± 1, and the average linewidth was 6.6 ± 2.0 Hz. Under 1 % of the voxels contained [90 % GM and 20 % had WM fractions [90 %, i.e., could be considered ''pure.' ' The spectra summed from all the 480 VOI voxels (equivalent to the numerator of Eq. 3) from every subject overlaid with their fits are shown in Fig. 3 . They exhibit NAA, Cr, Cho and mI SNRs of 561 ± 74, 265 ± 34, 228 ± 32 and 128 ± 17, a dramatic 22-fold gain (approximately 480 ) over the original 0.75-cm 3 voxels (compare Fig. 3 with Fig. 1d ) and linewidths of 6.5 ± 0.6 Hz retaining the single-voxel spectral resolution [18] .
The metabolic concentrations in patients and controls in the whole VOI (Eq. 3) as well as in its WM and GM moieties (Eq. 4) are given in Table 2 , and their distributions are plotted in Fig. 4 . Cr, Cho and mI concentrations in patients were not different from the concentrations in controls either in the VOI, or in the WM or GM. The NAA concentrations, however, were significantly lower in the VOI in patients (7.4 ± 0.6 vs. 7.9 ± 0.6 mM, p = 0.0180) and in their WM (7.2 ± 0.8 vs. 7.7 ± 0.6 mM, p = 0.0125) but not in the GM, as shown in Fig. 4 . While the reduced VOI NAA concentrations showed a trend towards significance upon application of Bonferroni correction for multiple comparisons, the WM change remained significant. To take disease duration into account we looked for associations between all concentrations and time since injury, and found significant Pearson and Spearman correlations in WM Cho (0.004 mM/day, r = 0.4, p = 0.043, and r = 0.43, p = 0.028) and Pearson correlation in WM Cr (0.013 mM/day, r = 0.39, p = 0.049) as shown in Fig. 5 .
Discussion
H-MRS sensitivity to mTBI
The advantages of 1 H-MRS over other quantitative MR techniques are specificity to injury type through the quantification of metabolites indicative of different processes, and sensitivity to nonstructural injury and to GM status. Since the first 1 H-MRS study of mTBI implicated the splenium of the corpus callosum [28] , abnormalities have been reported in the parietal, temporal, occipital [29, 30] and frontal [30] [31] [32] [33] lobes, pericontusional [34, 35] and supraventricular areas [16, 17] . However, in the same regions, some cohorts show abnormalities [17, 31] and others do not [29] . Direct comparisons of mTBI findings is difficult, however, due to different times since injury, injury heterogeneity, use of single-voxel 1 H-MRS and the use of metabolic ratios that assume stable Cr concentrations. For example, lower NAA/Cr ratios, which are usually attributed to NAA reductions, may be due to increased Cr [16, 17] . Indeed, following their pioneering study, Cecil et al. [28] attributed lower NAA/Cr in the splenium to a deficit in NAA, whereas absolute quantification in that structure revealed normal NAA and increased Cr [16] . Yet only four mTBI 1 H-MRS studies have used absolute quantification [16, 17, 30, 36] , and just one in a substantial volume [30] . Although the latter also showed WM reduced NAA, it included patients with moderate TBI, and hence it is not directly comparable to our study.
Two main points can be deduced from past research. First, mTBI is likely a diffuse/multifocal condition with no specific region(s) consistently involved. Subjectively chosen ROIs, therefore, may miss pathology in some patients, reducing the statistical power and underscoring the need for extensive volume coverage. Second, higher sensitivity in 1 H-MRS is needed, e.g., of the 25 ROIs in one study, almost 70 % had consistent trends for abnormalities, without statistical significance [29] . With the use of single voxels, however, focal disease cannot be differentiated from diffuse disease, and SNR, spatial resolution (partial volume) and coverage must be balanced. Specifically, small ROIs may lack sensitivity and bigger ones suffer from a GM/WM/CSF partial volume effect that can lead to apparent variations in their metabolite levels, confounding the detection of injury-related changes (see the cautionary note section below).
To address both sensitivity and limited coverage and to test the hypothesis that mTBI results in diffuse sequelae, we used a large (360 cm 3 ) VOI in which every voxel's spectrum contributed to calculating the concentration of each metabolite [18, 19] . Analyzing many (480) voxels simultaneously increased the precision, reflected by a coefficient of variation in the controls of about 10 %, as good or better than other 1 H-MRS methods. Importantly, any abnormalities detected this way must be diffuse since focal changes would be averaged out.
Diffuse abnormalities
It is well documented that TBI involves diffuse changes that may determine adverse outcomes [37, 38] . While hemorrhages are a marker for DAI on conventional imaging, most mTBI patients have unremarkable MRI/CT scans [11] and are rarely available for post-mortem study. Consequently, hypotheses on the pathology of mTBI are mostly based on histology of more severe TBI and animal models that lack the heterogeneity of human injury [38] . Fortunately, indirect evidence of mTBI changes has been obtained by quantitative MR methods, e.g., DTI [13] , functional MRI [14] and 1 H-MRS [15] . If the injury loci are different among patients [39] , however, ROI-based studies cannot differentiate focal from diffuse injury. Our results support the DAI hypothesis in mTBI.
Axonal pathology
Axons are known to be vulnerable to the inertial forces of blunt head trauma. A large body of evidence from ex vivo animal and human TBI studies suggests that the initial site of injury is the axolemma via disruption of ionic channels [38, 39] . Calcium influx impairs axonal transport, resulting in axonal swelling and potential axotomy [8, 9] that may be followed by Wallerian and retrograde degeneration and ultimately cell necrosis or apoptosis [9] .
Cell death cannot be distinguished from dysfunction on the basis of the observed NAA decrease in the WM. The latter, however, is supported by the lack of difference in Cr, Cho and mI levels between patients and controls. Normal Cho levels in patients may indicate absence of fragmented myelin from axon swelling or degeneration, as also suggested by DTI data [40] . Furthermore, normal mI and Cr levels that originate from intracellular stores in astrocytes [41] may represent lack of astroglial hypertrophy or hyperplasia from the astroglial scarring that typically forms on severed axons that is associated with permanent neuronal injury in more severe TBI [42] . In addition, normal NAA levels in the GM found in this and other mTBI whiskers 95 %; asterisks outliers). The difference in NAA concentration in the whole VOI between patients and controls is significant, and the difference is entirely attributable to the pathology in the WM studies [16, 17] suggests no cell body injury from Wallerian degeneration. This process in humans, however, is thought to take several months [8] , and it can be conjectured that the correlations between the increases in the concentrations of Cho and Cr with time in our cohort may represent progression. Given their cross-sectional nature, however, these correlations need to be interpreted with caution until verified in a longitudinal study. While it is unclear whether cell death is characteristic of early mTBI, even if it occurs it is unlikely to be widespread [9, 39] . Rather, axons may convert to a dysfunctional state from which they may recover [9] , as evidenced by NAA levels in serial 1 H-MRS studies [32, 33, 43] . Our data support the current consensus that brain injury is on a continuum [11, 39, 40] , i.e., DAI occurs in mTBI to a lesser degree than in more severe trauma. In addition, if axonal dysfunction and not death dominates mTBI pathology, it is important to reiterate the danger of a second traumatic event [39] , and underscore potential benefits of suitable therapy.
Finally, only two patients (8 %) had (potentially) injuryrelated MRI findings, which would qualify their mTBI as ''complicated'' [11] . This is much lower than the 17 % rate of CT findings reported by Stein and Ross [44] in 1,538 patients, and may reflect the fact that 80 % of our patients had a GCS score of 15 that is associated with a 5 % findings rate [45] . Since it is well known that severity differs across the 'mild' range, i.e., not all GCS scores in mTBI are equivalent [46] , it is noteworthy that our patient population suffered relatively milder (more subtle) injury than commonly seen in mTBI. Our results, therefore, suggest the presence of DAI in patients with mostly normal GCS scores and MRI scans, i.e., injury missed by the clinical and radiological examinations.
A cautionary note
Even at relatively high (0.75 cm 3 ) spatial resolution, only 20 % of the VOI voxels contained 90 % or more WM (considered ''pure'') and under 1 % were over 90 % GM. The different GM and WM metabolite concentrations present a confounding scenario. Different placement (in a serial or cross-sectional study) could alter a voxel's WM/ GM fractions, and hence its 1 H-MRS signal, regardless of any underlying pathology. Since early changes in mTBI are small, placing a voxel in a WM region with an unaccounted for GM partial volume will boost its NAA signal (which is about 15 % higher in the GM) sufficiently to offset its pathology-associated deficit of about 7 % or cause enough change in the signal to render differences insignificant. This underscores the importance of tissue segmentation, and that attempts to place voxels in ''pure'' WM or GM to circumvent this confounding scenario are unlikely to be reliable.
Limitations
This study was also subject to some limitations. First, since it was geared to maximize sensitivity at the expense of localization (although the original 3D data remained available), it was insensitive to focal changes that may have occurred only in specific small brain region(s). For example, while Cr levels were normal in the global WM, this may not necessarily be the case locally [16, 17] . For our approach to yield significant differences, however, changes must be present in a substantial part of our VOI. Therefore this study demonstrated not the absence of local injury but rather the presence of a diffuse component. Second, while the study demonstrated that this diffuse injury is axonal, its correspondence to histopathologically defined DAI [8, 47] remains unclear. Also known as ''traumatic axonal injury'', DAI is characterized by the presence of axonal swellings which can only be conclusively diagnosed post mortem [47] . Structurally intact axons can also be affected [47] , however, and diffusely lower NAA levels can represent manifestations of both types of DAI sequelae with an unknown contribution from each. Third is the assumption that GM and WM metabolite concentrations do not vary much over the VOI. While concentrations between tissue types differ significantly, within-tissue variations are small and in the forebrain exist only for NAA and Cho (mostly between the thalamus and cortical GM) [48] . If these differences were the same in all subjects, the only constraint would be that the changes be uniform (all increases or all decreases), a reasonable assumption given the decreases in NAA levels, and the increases in Cr, Cho and mI levels reported in TBI [15] . Fourth, although our VOI covered substantially more brain than most previous studies, it excluded most of the cortex (it contains about 40 %, of the approximate 470 cm 3 WM volume of the brain [49] , as well as cortical GM and all deep GM structures). Finally, the time required for acquisition and postprocessing may limit the clinical application of the technique in its current form.
Conclusion
We report evidence of DAI in patients with recent ''noncomplicated'' mTBI assessed by global quantitative 1 H-MRS. The lack of glial WM abnormalities and any GM injury within 2 months of mTBI suggests white matter dysfunction rather than degeneration, and underscores the potential for axonal recovery.
